Vitrafy Life Sciences Ltd (ASX: VFY) — Perfil da empresa, notícias e dados financeiros
Vitrafy Life Sciences Ltd is a biotechnology company that develops controlled-rate freezing hardware and intelligent cloud software for cryopreservation workflows.
Vitrafy Life Sciences Ltd
Vitrafy Life Sciences Ltd is a biotechnology company that develops controlled-rate freezing hardware and intelligent cloud software for cryopreservation workflows. The company's ecosystem integrates precision-engineered freezing equipment with cloud-based software to preserve biological materials, including human blood platelets, cell and gene therapy T-cells, and animal reproductive materials. Vitrafy serves clinical healthcare, life sciences research, combat casualty care, and aquaculture industries by providing automated, liquid-nitrogen-free cryopreservation technology designed to maintain post-thaw viability and streamline bio-material supply chains across global research and medical facilities.
Resumo
Operações
Produtos e/ou serviços de Vitrafy Life Sciences Ltd
- Precision Controlled Freezing Hardware: Custom-engineered hardware delivering rapid, liquid-nitrogen-free cryogenic freezing with high throughput per hour, reaching target cryogenic temperatures under five minutes to preserve cell viability during cryopreservation.
- Intelligent Cryopreservation Software: Cloud-connected workflow management software that monitors, tracks, and logs cryopreservation data in real time, standardizing freezing protocols and ensuring complete chain-of-custody tracking across biological sample lifecycles.
- Blood and Platelet Cryopreservation Solutions: Specialized freezing technology designed for human blood services and combat casualty care, improving post-thaw recovery rates of blood platelets to eliminate wash steps and extend clinical shelf life.
- Cell and Gene Therapy Processing: Advanced cryopreservation workflows for cell therapy developers, ensuring post-thaw viability of fragile T-cells comparable to fresh samples to streamline complex therapy manufacturing and supply chains.
- Animal Reproduction and Aquaculture Applications: Cryogenic preservation solutions tailored for livestock breeding programs and aquaculture operations, enhancing post-thaw sperm quality and fertilization success rates across commercial aquatic and terrestrial animal species.
- Research and Optimization Services: Advisory and testing services for biotechnology laboratories and research institutions, optimizing bio-material freezing protocols and validating cryopreservation workflows to improve post-thaw quality at commercial scale.
equipe executiva do Vitrafy Life Sciences Ltd
- Brenton Michael Leslie OwensCo-Founder, MD, CEO & Executive Director
- Simon Thomas MartinChief Financial Officer
- Heather PidcokeChief Science Officer
- Timothy P. CostelloEVP& Chief Commercial Officer
- Michael SapountzisCompany Secretary
Últimas notícias sobre a Vitrafy Life Sciences Ltd
Comunicados recentes
O que a Vitrafy Life Sciences Ltd (VFY) comunicou ao mercado, do mais recente para o mais antigo.
- Investor Roadshow Presentation
- Change to CEO Remuneration and Employment Terms
- Vitrafy Share Purchase Plan Opens - SPP Offer BookletFato relevante
- Cleansing Notice
- Application for quotation of securities - VFY
Principais indicadores financeiros
Resultados divulgados pela Vitrafy Life Sciences Ltd, em AUD.
- Cap. de mercado
- 173,1 mi
- Receita (TTM)
- 209 mil
- P/L
- —
- LPA (diluído, TTM)
- -0.3
- Dividend yield
- —
- Margem de lucro
- 0.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 168,7 mil | -20,4 mi | -16,2 mi | |
| 65,1 mil | -16,6 mi | -32,7 mi | |
| 37 mil | -10,7 mi | -10,4 mi | |
| 32 mil | -9,2 mi | -7,8 mi |